Evidence map›Paper›PMID 32494062›Full record

ArticleNature medicine2020

Author Correction: Caring for patients with cancer in the COVID-19 era.

Joris van de Haar, Louisa R Hoes, Charlotte E Coles, Kenneth Seamon, Stefan Fröhling, Dirk Jäger, Franco Valenza, Filippo de Braud, Luigi De Petris, Jonas Bergh and 11 more

Abstract readPublished Erratum
In one paragraph

Article in Nature medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Observational
  2. Palliative medicine · 2022
    Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Joris van de Haar *Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Louisa R Hoes *Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Charlotte E ColesCancer Research UK Cambridge Cancer Center, Cambridge, UK.
Kenneth SeamonCancer Research UK Cambridge Cancer Center, Cambridge, UK.
Stefan FröhlingGerman Cancer Consortium, Heidelberg, Germany.
Dirk JägerDepartment of Medical Oncology, National Center for Tumor Diseases Heidelberg and Heidelberg University Hospital, Heidelberg, Germany.
Franco ValenzaUniversità Statale di Milano, Milan, Italy.
Filippo de BraudUniversità Statale di Milano, Milan, Italy.
Luigi De PetrisDepartment of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
Jonas BerghDepartment of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
Ingemar ErnbergDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.
Benjamin BesseGustave Roussy Cancer Campus, Villejuif, France.
Fabrice BarlesiGustave Roussy Cancer Campus, Villejuif, France.
Elena GarraldaDepartment of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
Alejandro Piris-GiménezDepartment of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.
Michael BaumannGerman Cancer Consortium, Heidelberg, Germany.
Giovanni ApoloneFondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Jean Charles SoriaGustave Roussy Cancer Campus, Villejuif, France.
Josep TaberneroDepartment of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.ORCID http://orcid.org/0000-0002-2495-8139
Carlos CaldasCancer Research UK Cambridge Cancer Center, Cambridge, UK. carlos.caldas@cruk.cam.ac.uk.ORCID http://orcid.org/0000-0003-3547-1489
Emile E VoestDivision of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. e.voest@nki.nl.ORCID http://orcid.org/0000-0001-8249-9586

Funding

Department of Health NIHR300024
6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32494062
PMCPMC7269160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.